Guide to buying Pfizer stock in Canada

Pfizer is a drug manufacturers - general business based in the US. Pfizer stocks (PFE) are listed on the NYSE, and all prices are listed in US Dollars.

At its last market close, Pfizer stock price was $24.17, which is an increase of 1.9% over the previous week. Pfizer employs 75,000 staff and has a trailing 12-month revenue of around $63.3 billion.

Keep reading to see up-to-date Pfizer stock price and performance data, along with a step-by-step guide for how to buy Pfizer stock in Canada.

Pfizer (PFE) stock summary

Company stock name	Pfizer Inc
Stock ticker symbol	PFE
Exchange	NYSE
Open	$24.35
High	$24.41
Low	$24.10
Close	$24.17
Adjusted closing	$24.17
Volume The number of stocks traded during the day	27,485,000
52-week stock price range	$21.97 – $28.28
Where to buy Pfizer stock	Buy on Questrade

The values in this table are accurate as of the market close on July 9, 2026, and all amounts are in USD.

Can I buy Pfizer stock in Canada?

Yes, you can buy Pfizer stock in Canada. You simply need to open a brokerage account with an online trading platform that supports stocks on the NYSE exchange. Platforms like Questrade and Wealthsimple will allow you to directly buy Pfizer stock from within Canada.

Dive deeper: Detailed guide on how to buy stocks in Canada

Our top picks for where to buy Pfizer stock

Pfizer stock chart (NYSE: PFE)

This chart tracks Pfizer stock price performance over time.

Pfizer stock price

Pfizer's stock price at the last available market close was $24.17 (as of July 9, 2026). For comparison, seven days ago Pfizer's stock price was $24.32. A full 30 days ago it was $26.21, and a year ago it was $25.65.

Is Pfizer stock a buy or sell right now?

The technical analysis gauge above shows real-time buy or sell ratings and analysis for Pfizer stock based on your selected timeframe. It uses three widely followed indicators—moving averages, oscillators and pivots—but this does not represent investment advice or a guarantee of success. Finder may not concur with these signals and accepts no responsibility for the performance of your stocks.

Can I buy Pfizer stock on the TSX?

No, you cannot buy Pfizer stock on the TSX because Pfizer stock is not listed on the TSX. Instead, Pfizer stock is listed on the NYSE under the symbol "PFE."

That said, if you're wondering how to invest in Pfizer stock in Canada, you still have the option to do so by opening a trading account with a Canadian brokerage that gives you access to NYSE, like Questrade or Wealthsimple.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Pfizer stock dividends

Pfizer dividend payout ratio: 56% of net profits

Recently Pfizer has paid out, on average, around 56% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 7.12% of the current stock value.

This means that, over a year, based on recent payouts (which are not a guarantee of future payouts), Pfizer shareholders could enjoy a 7.12% return on their shares in the form of dividend payments. In Pfizer's case, that would currently equate to about 1.72 per share.

Pfizer's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

Pfizer's next dividend payout is expected around September 1, 2026. To benefit, you'll need to buy before July 24, 2026.

Pfizer stock performance metrics

Here are some common key metrics for Pfizer stock that analysts often use to help gauge a stock's value—P/E ratio, PEG ratio and EBITDA.

• Pfizer's P/E ratio

  Pfizer's current share price divided by its per-share earnings (EPS) over the past 12 months gives a trailing price/earnings (P/E) ratio of roughly 18x.

  That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stock or simply that they're under-valued.

• Pfizer's PEG ratio

  Pfizer's price/earnings-to-growth (PEG) ratio comes out to about 2.8252.

  The PEG ratio provides a broader view than the P/E ratio alone, as it factors in Pfizer's expected earnings growth.

• Pfizer's EBITDA

  Pfizer's EBITDA (earnings before interest, taxes, depreciation and amortization) is $25.5 billion.

Has Pfizer stock ever split?

Pfizer's stocks were split on a 1054:1000 basis on November 16, 2020. So, if you had owned 1000 shares the day before the split, the next day you'd have owned 1054 shares. This wouldn't directly have changed the overall worth of your Pfizer stocks, just the quantity.

However, indirectly, the new 5.4% higher stock price could have impacted the market appetite for Pfizer stocks, which in turn could have impacted Pfizer's stock price.

How volatile is Pfizer stock?

Over the last 12 months, Pfizer's stocks price has ranged from $21.97 to as high as $28.28. Pfizer's beta measurement of stock volatility is 0.31. For comparison, the market (NYSE) average beta is 1. This would suggest that Pfizer's stocks are less volatile than average (on this exchange).

Some analysists use "beta" to gauge a stock's volatility. Beta is a popular way to measure a stocks volatility in relation to the market. Here is a breakdown of Pfizer's beta stock volatility rating.

Pfizer Inc company and revenue performance

Market Capitalization The total market value of Pfizer's outstanding shares	$137.8 billion
Gross profit (TTM)	$47.4 billion
Operating margin (TTM)	31.62%
Profit margin	11.83%
Revenue (TTM)	$63.3 billion
Return on assets (TTM)	5.69%
Return on equity (TTM)	8.31%
Earnings per share (TTM)	$1.31
50-day moving stock price average The average share price over the last 50 days	$25.44
200-day moving stock price average The average share price over the last 200 days	$25.87

All dollar amounts in this table are in USD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on July 9, 2026.

Pfizer company profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite.

The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands.

In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin.

The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models.

• Common company-related questions about Pfizer

  What percentage of Pfizer is owned by insiders or institutions?
  Currently 0.095% of Pfizer stocks are held by insiders and 69.456% by institutions.

  How many people work for Pfizer?
  Latest data suggests 75,000 work at Pfizer.

  When does the fiscal year end for Pfizer?
  Pfizer's fiscal year ends in December.

  Where is Pfizer based?
  Pfizer's address is: 66 Hudson Boulevard East, New York, NY, United States, 10001-2192

  What is Pfizer's ISIN number?
  Pfizer's international securities identification number is: US7170811035

  What is Pfizer's CUSIP number?
  Pfizer's Committee on Uniform Securities Identification Procedures number is: 717081103

Compare trading platforms to buy Pfizer stock

Compare special offers, low fees and a wide range of investment options among popular trading platforms in Canada. Note that the dollar amounts in the table below are in CAD.

Related: Compare the best stock trading platforms in Canada

Do I have to pay tax on gains from Pfizer stock sales in Canada?

Yes, you'll need to pay taxes in Canada on investment income, which includes any profit from selling Pfizer stock. The CRA taxes investment income from stocks in Canada based on three main factors:

1. Investment income. Investment income includes money earned from interest, dividends or capital gains, which may affect how much you have to pay in taxes on stock sales in Canada.
2. Investor type. Your investment income will be taxed differently depending on whether you're a regular investor or a day trader (which means you buy and trade stocks on a daily basis as your primary form of income).
3. Tax bracket. The higher your tax bracket, the more you'll pay on income from stock sales. Your tax bracket depends on your gross income (minus deductions).

You can learn more about the tax implications of selling stocks in Canada here.

Frequently asked questions about Pfizer stock

• Can I buy Pfizer stock directly as a Canadian investor?

  Yes, Canadian investors can buy Pfizer stock directly through various online brokerage platforms available in Canada. You can compare trading platform options and fees for buying Pfizer stock in our table here.

• How much is Pfizer stock worth?

  As of the last market close (on July 9, 2026), Pfizer stock is worth $24.17 per share.

• Can Canadians buy American stocks?

  Yes, Canadians can buy American stocks through Canadian trading platforms that give access to American stock exchanges such as the NYSE and Nasdaq. The good news is that most Canadian brokerage platforms, like Questrade, Interactive Brokers, Moomoo and Wealthsimple, give access to US exchanges. Read our full guide on how to buy US stocks in Canada to learn more.

• Can I buy fractional shares of Pfizer stock?

  Yes, it may be possible to buy fractional shares of Pfizer stock depending on the trading platform you're signed up with. Fractional shares can allow you to invest in Pfizer stock even when you can't afford its full share price. You can read our full guide to how fractional shares work to learn more.

  The table below shows trading apps in Canada that offer fractional shares:

  4 of 4 results

  Finder Score	Available Asset Types	Account Types	Stock Trading Fee	Monthly Account Fee
  Promoted 9.6 Excellent Questrade	9.6 Excellent	Stocks, Bonds, Options, Mutual Funds, Index Funds, ETFs, Forex, GICs, Precious Metals, IPOs	RRSP, RESP, RRIF, TFSA, Personal, Joint, FHSA, Margin	$0	$0	Get up to $500 when you open and fund your first Questrade self-directed account. Conditions apply. Offer ends July 23, 2026.. T&Cs apply.	Go to site View details Compare product selection Compare	loading
  8.6 Great Wealthsimple Investing	8.6 Great	Stocks, Options, ETFs, Cryptocurrency	RRSP, TFSA, Personal, Margin	$0	$0	Get a 1% match cash bonus on eligible $25,000+ transfers from other financial institutions to your Wealthsimple Self-directed Investing and Managed Investing accounts. T&Cs apply.	Go to site View details Compare product selection Compare	loading
  9.4 Excellent Interactive Brokers	9.4 Excellent	Stocks, Bonds, Options, Index Funds, ETFs, Forex, Currencies, Futures	RRSP, TFSA, Personal, Joint, Business, FHSA, Margin	Min $1.00, Max 0.5%	$0	View details Compare product selection Compare	loading
  8.6 Great Moomoo	8.6 Great	Stocks, Options, ETFs	RRSP, TFSA, Personal, FHSA, Margin	$1.49/stock	$0	Get up to 30 free stocks, 6% on uninvested cash, commission-free trades for 30 days and up to $2,300 in cash rewards. Offer ends August 31, 2026. T&Cs apply.	View details Compare product selection Compare	loading

  loading

  Load More

  Showing 4 of 4 results

  Finder Score for stock trading platforms

  To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.

  Read the full methodology

Related: New to stock trading? Compare brokers and get tips for investing.

Important information: Powered by Finder.com. This information is general in nature and is no substitute for professional advice. It does not take into account your personal situation. This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for most investors. You do not own or have any interest in the underlying asset. Capital is at risk, including the risk of losing more than the amount originally put in, market volatility and liquidity risks. Past performance is no guarantee of future results. Tax on profits may apply. Consider the Product Disclosure Statement and Target Market Determination for the product on the provider's website. Consider your own circumstances, including whether you can afford to take the high risk of losing your money and possess the relevant experience and knowledge. We recommend that you obtain independent advice from a suitably licensed financial advisor before making any trades.